Comments on: Novartis, Proteus pilot to lead to exclusive deal?

By: NHS tests Proteus Biomedical’s smart pills | mobihealthnews

NHS tests Proteus Biomedical’s smart pills | mobihealthnews — Thu, 12 Aug 2010 21:28:56 +0000

[...] giant Novartis has already piloted Proteus‘ technology for a small 20 patient study that tracked patients’ compliance with their blood [...]

By: Novartis invests $24M in Proteus Biomedical | mobihealthnews

Novartis invests $24M in Proteus Biomedical | mobihealthnews — Tue, 12 Jan 2010 13:47:47 +0000

[...] to license Proteus Biomedical’s sensing technology for organ transplantation. (That must be the kind of exclusive deal Novartis had in mind when the two companies announced their collaboration on a pilot last [...]

By: Sleep deprivation; Bluetooth; Tips for adherence | mobihealthnews

Sleep deprivation; Bluetooth; Tips for adherence | mobihealthnews — Tue, 03 Nov 2009 15:30:39 +0000

[...] Despite that, Novartis isn’t shunning the tech side of adherence either: The company recently inked a deal with intelligent medicine start-up Proteus Biomedical. Here’s more on the five tips for [...]

By: Microchip Implant Controversy: a Mark of the Beast or the Coming “Singularity”? « NWO News

Tue, 13 Oct 2009 22:58:54 +0000

[...] finally: Proteus CEO Andrew Thompson believes his company’s market opportunity could be $100 billion. This is delusional. The serious debate here is over privacy and tracking concerns, and whether [...]

By: Microchip Implant Controversy: a Mark of the Beast or the Coming “Singularity”? « Beyond The Curtain

Mon, 12 Oct 2009 21:45:50 +0000

By: Novartis Chip Implant Texts Your Phone When You Need Another Pill : Refuse Resist

Sat, 10 Oct 2009 16:46:01 +0000

[...] implanted computer chips into the shoulders of 20 patients taking the blood pressure drug Diovan; the chips sent text messages to their cellphones when it was time to take the next pill. The experiment was designed to improve “compliance.” [...]

By: Impactiviti Daily 100909 « Impactiviti blog

Impactiviti Daily 100909 « Impactiviti blog — Fri, 09 Oct 2009 15:06:59 +0000

[...] all for improved patient compliance. But this and this kinda give me the creeps. Not sure I want that kind of technology in my body, giving [...]

By: Big RxBrother is Watching – Who Else Dialed In?

Big RxBrother is Watching – Who Else Dialed In? — Fri, 09 Oct 2009 13:05:18 +0000

[...] they’ve implanted chips in patients’ shoulders that monitor their drug usage. As reported in mobihealthnews, “patients are taking blood pressure drug Diovan and the study organizers track their compliance [...]

By: Big RxBrother is Watching – Who Else Dialed In? « Palio –– Never Be Forgotten

Thu, 08 Oct 2009 14:25:53 +0000

By: David Doherty

David Doherty — Sat, 26 Sep 2009 16:11:37 +0000

Hi Al,

I take it from your comment that your approach to Mobile Health is from the Mobile rather than the Health side.

Whilst no doubt there can be some truth in what you write, drug compliance isn’t as straight forward as this for a number of reasons including

1) Poor compliance is often because a patient elects not to buy/take their medication. A good example of this might be because it has a side effect that makes them feel ill. Using the proteus technology a carer can prescribe more accurately ie. reducing or increasing dose on an individual basis in order to better manage their health and the side effects. This will encourage patients to buy more medication and to have more loyalty to that medication brand. This is something that “Pharma investors” are most definitely very interested in.

2) Some issues with compliance relate to out of date medications. Obviously identifying these is in the best interest of sales AND avoids the patient safety issues of expired medications. This is also something that “Pharma investors” are most definitely very interested in.

It is worth noting that the major customer for prescription drugs are Doctors. This custom is vulnerable to change if the brand lacks the effectiveness of other rival brands because Doctors need to keep their customers happy and healthy. Ensuring patients have the optimally tailored medication experience is therefore most definitely not just “marketing crap”.